Top Biotech Companies (3,704)
Xenon Pharmaceuticals is a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need. Our lead molecule, azetukalner, is a novel, potent, selective Kv7 potassium channel opener in Phase 3 clinical trials for the treatment of epilepsy, major depressive disorder (MDD) and bipolar depression (BPD). We are also advancing an early-stage portfolio...
We believe in harnessing science for human good. And so we work day and night, around the world, to deliver answers for all your health questions—whether you’re a provider, drug developer, hospital, medical researcher or patient. That means everything from advancing diagnostic testing to helping launch new drugs, to offering new perspectives through data - all drawing from a deep...
PF is a consulting firm providing biomanufacturing strategy and execution. Our services include turnkey capital projects and facility builds; owner's representation and program/project management; validation; quality, regulatory and compliance; engineering and automation and more. We partner with startup and established pharmaceutical companies, advanced therapy companies, academia, hospitals, financial institutions, and CROs/CMOs. One of our core values is giving back. Volunteering at...
Absentia Labs is building an AI-powered platform for virtual drug testing on whole organisms to transform early drug discovery. By developing foundation models that predict how medicines behave in the human body, they aim to replace traditional animal testing with in-silico whole-organism models, reducing late-stage pharmaceutical failures and accelerating the creation of safer medicines through computational biology and mechanistic toxicology.
Zai Lab Limited is an innovative, research-based, commercial-stage biopharmaceutical company based in China and the United States.
At Solugen, we believe planet-scale change starts with the chemistry we use every day. So we’ve built the world’s first clean molecule factory. Fusing biology with chemistry and technology to make the materials we need to sustain life on Earth. We’re pioneering the way to scale synbio. One that uses evolved enzymes, plant-based feedstocks and clean, catalytic reactions to make 90%...
ArsenalBiosciences, Inc., is a clinical stage programmable cell therapy company focused on the realization of solid tumor cell therapy to defeat cancer. Our discovery engine comprises precise CRISPR-enabled genome editing, integrated circuits incorporating logic gates for improved tumor targeting, and therapeutic enhancements enabling multiple pharmaceutical functions. With our programmable and computationally driven approach, we aim for enhanced and broader efficacy,...
At Eucalyptus, we run a trusted group of digital healthcare clinics on our telehealth platform including Pilot (men’s health), Kin (fertility), Software (dermatology) and Juniper (weight loss and menopause). Our mission is to bring high-touch, high-quality healthcare to patients around the world by empowering practitioners with technology. Since 2019, we’ve facilitated over one million consultations across Australia, the UK and...
As a world-leading drug device combination solutions specialist, our purpose of putting patients first enables us to design and manufacture devices that maximize treatment efficacy. We are the utmost holistic partner and help our customers succeed in the sprint to market. From early device strategy to state-of-the-art manufacturing, we're committed to the highest quality standards. Agile and open-minded, we work...
Actithera is a radiopharmaceutical biotech company that designs and develops next-generation radioligand therapies (RLTs) to treat cancer. Using proprietary medicinal chemistry, including covalent-targeting and an isotope-agnostic philosophy, the company creates targeted therapies that maximize tumor radiation dose while minimizing exposure to healthy tissues to improve the lives of cancer patients with high unmet medical needs.
Vitely provides analytical testing and laboratory services for life sciences organizations while developing enabling technology. Its VitelyBio division offers microbiology and in‑vitro testing and regulated lab processes; VitelyTech delivers software development, automation, and data‑management solutions to support R&D workflows, regulatory compliance, and data integrity for pharmaceutical and biotech clients. The company focuses on high-quality, compliant analytical services and integrated digital...
KBI Biopharma is an award-winning biopharmaceutical contract services organization providing fully-integrated, accelerated drug development and biomanufacturing services to pharmaceutical and biotechnology companies globally. With each of our 500+ client partners, we have worked closely to personalize and rapidly accelerate their drug development programs. Built upon a foundation of world-class analytical capabilities, we deliver efficient process development and clinical and commercial cGMP...
KBI Biopharma's Top Stability & Growth Strengths
Strong Market Position & Advantage: Feedback suggests KBI’s integrated Selexis-enabled CLD, analytics depth, and end-to-end biologics services provide a specialist edge among mid-tier CDMOs. Successful 2024 FDA inspection and an expanded commercial contract signal credibility beyond early clinical stages.
Strategic Partnerships: Operational consolidation with Selexis and alliances such as Argonaut and Infinimmune indicate a deliberate partner strategy to broaden drug substance-to-drug product solutions. These moves position KBI to compete for larger, longer-term programs.
Customer Loyalty & Retention: The extension and expansion of a commercial manufacturing agreement with a leading pharma through 2029, with roughly $250M in additional purchases, points to durable demand from key customers. This multi-year commitment underscores continuity from early work into commercial supply.
Rivia is a Zurich-based technology company building a data engine that powers the future of clinical trial intelligence. Rivia was founded on the belief that new drugs can be brought to market more successfully with a fraction of today’s capital. Over the past two years, European and US based biotechs running global clinical trials on Rivia have demonstrated measurable impact,...
Prime Medicine was founded to bring the promise of gene editing to patients. We use Prime Editing, a next-generation technology that can “search and replace” to restore normal genetic function almost anywhere in the genome. Prime Editing searches to find the precise place in the genome to edit and replaces the segment of faulty DNA with a correct copy of...
Sitero is a next-generation, site-focused clinical research organization (CRO) for life sciences and institutional research organizations that helps get treatments to market safer and faster through tech-forward services that streamline research. Accelerate your clinical trial, drive compliance and safety, and unlock innovation with access to powerful technology and world-class services. Sitero combines the expertise of a tenured team with a...
Emmaus Life Sciences, Inc. is a biopharmaceutical company engaged in the discovery, development and commercialization of innovative treatments and therapies primarily for rare and orphan diseases.
Morgridge Institute for Research is a nonprofit biomedical research institute affiliated with the University of Wisconsin–Madison. It pursues fearless, curiosity-driven science to deepen understanding of biology and advance human health. The institute supports interdisciplinary investigators, develops transformational tools, and connects basic research with translational outcomes, while also fostering scientific curiosity, education, and public engagement through its partnership with the university...
Cytel enables decision-makers in the life sciences to unlock the full potential of their products. From navigating uncertainty to proving value, Cytel’s 30 years of global expertise in consulting, data-driven analytics, and industry-leading software helps biotech and pharmaceutical companies transform intelligence into confident decisions. We have an uncompromising commitment to scientific rigor and high standards of operational excellence, which are...
Cytel's Top Stability & Growth Strengths
Investor Backing & Capital Strength: Private-equity ownership by Astorg and Nordic Capital is positioned as support to accelerate Cytel’s next phase of growth and innovation, signaling access to growth-oriented capital and sponsorship.
Product Line Growth: East Horizon launched as a cloud-based evolution of Cytel’s trial-design software and has continued adding modules through 2025, indicating ongoing investment and expansion of the software offering.
Market Expansion: Multiple acquisitions in 2022–2023 (e.g., Stève Consultants and co.faktor) and an increase in offices from 2021 to 2023 indicate broader geographic coverage and capability expansion, particularly across Europe.
Vireo Health is a physician-led company dedicated to providing patients with best-in-class cannabis-based products and high quality care
Ultima Genomics is unleashing the power of genomics at scale. Our mission is to continuously drive the scale of genomic information to enable unprecedented advances in biology and improvements in human health. With humanity on the cusp of a biological revolution, there is a virtually endless need for more genomic information to address biology’s complexity and dynamic change—and a further...




.png)




























